Answers are grounded in this paper and cite their sources.
Selenium biology depends not only on total abundance but also on how selenium is allocated among molecular forms in proteins. Selenocysteine (Sec) is incorporated into selenoproteins, whereas selenomethionine (SeMet) can be retained more broadly throughout the proteome. Resolving these pools is limited by the incompatibility between complete protein hydrolysis and preservation of labile Sec. Here we tune α-haloacetate electrophilicity to identify a reaction window in which sodium chloroacetate selectively converts Sec into acid-stable carboxymethyl Sec without detectable modification of selenomethionine (SeMet) or methylselenocysteine. Coupling this stabilization chemistry with complete acid hydrolysis and HPLC-ICP-MS enables quantitative reconstruction of protein-bound selenium, achieving 97.3% mass balance closure in selenium-enriched yeast protein. Across foods and liver tissues, the method revealed contrasting SeMet-rich and Sec-dominant protein-bound selenium pools. In oncogene-driven hepatocellular carcinoma, tumour-associated Sec depletion was partially reversed by SeMet treatment, accompanied by marked accumulation of protein-bound SeMet. These results extend protein-bound selenium analysis from total abundance to molecular allocation, revealing how selenium is partitioned among molecular forms across biological systems and remodelled in disease.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: